VRSEF (Verisante Technology) 5-Year EBITDA Growth Rate: 35.50% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Verisante Technology 5-Year EBITDA Growth Rate?

Verisante Technology VRSEF 5-Year EBITDA Growth Rate is 35.50% as of Mar. 2026.

Verisante Technology's EBITDA per Share for the three months ended in Mar. 2026 was $0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 43.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 35.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Verisante Technology was 52.70% per year. The lowest was -11.40% per year. And the median was 33.20% per year.

Verisante Technology  (OTCPK:VRSEF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Verisante Technology 5-Year EBITDA Growth Rate Related Terms

VRSEF vs ABT, SYK, MDT: 5-Year EBITDA Growth Rate Comparison

For the Medical Devices subindustry, Verisante Technology's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verisante Technology 5-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Verisante Technology's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Verisante Technology's 5-Year EBITDA Growth Rate falls into.


Verisante Technology 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 35.50% mean?
Verisante Technology (VRSEF) has a 5-Year EBITDA Growth Rate of 35.50% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Verisante Technology and its competitors.
Is Verisante Technology's 5-Year EBITDA Growth Rate too high?
Verisante Technology's current 5-Year EBITDA Growth Rate is 35.50%.
How does Verisante Technology's 5-Year EBITDA Growth Rate compare to ABT and SYK?
Verisante Technology's 5-Year EBITDA Growth Rate of 35.50% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
A good 5-Year EBITDA Growth Rate depends on the Medical Devices & Instruments industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Verisante Technology and its competitors. Verisante Technology's current 5-Year EBITDA Growth Rate is 35.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verisante Technology stock overvalued right now?
Verisante Technology (VRSEF) has a current 5-Year EBITDA Growth Rate of 35.50%. The current 5-Year EBITDA Growth Rate is 35.50%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Verisante Technology (VRSEF), the current 5-Year EBITDA Growth Rate is 35.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Verisante Technology Business Description

Other Exchanges VER.H:Canada
Address 422 Richards Street, Suite 170, Vancouver, BC, CAN, V6B 2Z4
Verisante Technology Inc does not have any operations. It is currently seeking out opportunities to acquire a successful business such as a provider of cutting-edge technologies and services, offering scalable solutions.